Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 93124

3 recalled-product records grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
October 02, 2023
Product types
Drug
Classifications
Class I
Statuses
Terminated
Recalling firm wording
Pfizer Inc.

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

3 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 3

4.2% Sodium Bicarbonate Injection, USP 5 mEq/10 mL (0.5mEq/mL), Glass ABBOJECT Unit of Use Syringe, packaged as 1 vial and injector per carton, Rx only, Hospira Inc., Lake Forest, IL 60045, NDC 0409-5534-24

D-0100-2024
Recall number
D-0100-2024
Initiated
October 02, 2023
Classification
Class I
Status
Terminated
Recalling firm
Pfizer Inc.
Quantity
24,900 vials

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
Particulate Matter

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Presence of Particulate Matter: identified as glass.

Code information

Lot#: GJ5007, Exp. 8/1/2024

Distribution pattern

Nationwide in the US and Puerto Rico. The products were not distributed to government accounts or foreign consignees.

drug · product 2 of 3

1% Lidocaine HCl Injection, USP, 50mg/5mL(10mg/mL), Glass ABBOJECT Unit of Use Syringe, packaged as 1 vial and injector per carton, Rx only, Distributed by Hospira Inc., Lake Forest, IL 60045, NDC 0409-4904-11

D-0101-2024
Recall number
D-0101-2024
Initiated
October 02, 2023
Classification
Class I
Status
Terminated
Recalling firm
Pfizer Inc.
Quantity
21,390 vials

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
Particulate Matter

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Presence of Particulate Matter: identified as glass.

Code information

Lot#: 42290DK, Exp. 6/1/2024

Distribution pattern

Nationwide in the US and Puerto Rico. The products were not distributed to government accounts or foreign consignees.

drug · product 3 of 3

2% Lidocaine HCl Injection, USP, 100mg/5mL(20mg/mL), Glass ABBOJECT Unit of Use Syringe, packaged as 1 vial and injector per carton, Rx only, Distributed by Hospira Inc., Lake Forest, IL 60045, NDC 0409-4903-11

D-0102-2024
Recall number
D-0102-2024
Initiated
October 02, 2023
Classification
Class I
Status
Terminated
Recalling firm
Pfizer Inc.
Quantity
3,200 vials

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
Particulate Matter

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Presence of Particulate Matter: identified as glass.

Code information

Lot#: GH6567, Exp. 7/1/2024

Distribution pattern

Nationwide in the US and Puerto Rico. The products were not distributed to government accounts or foreign consignees.